Johnson & Johnson shares jump after UBS raises target to $320
Johnson & Johnson surged roughly 1.2% to $274.395 as UBS raised its price target from $280 to $320, with Barron's reporting the stock became a top Dow point contributor in early trading.
Johnson & Johnson NYSE:JNJ, the pharmaceutical and medical-technology powerhouse, surged roughly 1.2% to $274.395 Wednesday after UBS cranked its price target from $280 to $320.
Barron's reported that J&J became the Dow's biggest point booster in early trading.
Wall Street heard the message loud an…